Advance your next cancer research breakthrough.
In 2019 we welcomed the preclinical pharmacology oncology provider, MI Bioresearch, into the Labcorp family. Now you can access hundreds of cell line assays and tumor models, as well as thousands of potential oncology patients for clinical trials or explore an extensive library of oncology diagnostics.
When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools and experience to move life-changing drug candidates through non-GLP, preclinical development and oncology clinical trials quickly and efficiently.
We've helped hundreds of companies discover their next life-improving compound.
Immunotherapy & Adoptive Cell Therapy Support
We offer over 30 different syngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research. We are continually improving and expanding adoptive cell therapy capabilities:
PRECLINICAL ONCOLOGY RENOVATION
Fully invested in your fight against cancer from the very beginning
The fight against cancer starts in the lab. That’s why we’ve invested in a renovation that doubled the size of our preclinical oncology facility in Ann Arbor, Michigan. Here you can discover enhanced capabilities and greater capacity to speed up your preclinical oncology programs.